Industry news

U.S. Army scientists roll out innovative blood loss monitor device

Emily Wasserman / FiercePharma

As researchers target innovative technology geared toward military use, U.S. army scientists are developing a device that could monitor how long an individual is able to compensate for blood loss.

NIH to bankroll initiatives to build Cancer Genomics Cloud Pilots into R&D programs

Nick Paul Taylor / Fierce Biotech IT

The National Institutes of Health (NIH) is offering funding to research initiatives that make use of the Cancer Genomics Cloud Pilots. The NIH is hoping the next wave of projects will help the National Cancer Institute (NCI) decide how to establish computational infrastructure to support genomics research.

EMA Issues Guideline on Fast Tracking Drugs for Unmet Needs

BioPharm International

The European Medicines Agency (EMA) announced on July 27, 2015 that it has revised its guideline on the implementation of accelerated assessment and conditional marketing authorization to improve existing framework. These guidelines are part of European legislation targeting the acceleration of patient access to innovative therapies.

Health experts caution against wide range of scope devices amid superbug outbreaks

Emily Wasserman / FierceMedicalDevices

Duodenoscope devices have drawn the public's ire this past year, with the FDA and patients pushing back against the products in light of superbug outbreaks and mounting safety concerns. Now, healthcare experts are cautioning against a variety of scopes, saying similar devices could lead to potentially deadly infections.

In a first, drug using 3D printing technology gets FDA nod

Arathy S Nair / Reuters

The U.S. Food and Drug Administration has, for the first time, approved a drug that uses 3D printing technology, paving the way for potential customization of drugs to suit patients' needs.

Romania investigates suspected drug company bribes

Ben Hirschler / Reuters

Romanian anti-corruption prosecutors have conducted a series of searches at drug companies, hospitals and clinics this week to investigate suspected bribes paid to doctors for prescribing cancer drugs.

Scientists create noninvasive spinal stimulation tech to help paralyzed move

Emily Wasserman / FierceMedicalDevices

Spinal cord stimulation is the med tech trend du jour, and researchers are harnessing the technology to create a noninvasive method that helps restore movement in paralyzed individuals.

Europe's public biotechs blast past 2014 fundraising total in just 6 months

Nick Paul Taylor / Fierce Biotech

Biotechs listed on European stock exchanges have raised more money in the first half of 2015 than in all of last year, according to a report by Biocom. Over the first 6 months of 2015, €3 billion ($3.3 billion) flowed into Europe's 161 listed biotechs, one-quarter more than they added to their coffers in all of 2014.

Regulators in Europe propose bans on plants in China and India

Eric Palmer / FeircePharmaManufacturing

FDA actions taken against Indian drugmakers have grabbed a lot of attention in recent years, but Europe has also been pushing foreign suppliers to hit higher standards. Each country does its own inspections but then shares any issues it finds through a common website. Most recently, Italy flagged problems with three plants, two in China and one in India.

Report Calls for Measures to Preserve India’s Brand in Global Pharma Market

T.V. Padma / Life Sciences Connect

A new report to the government of India suggests the adoption of a slew of measures to help domestic pharma firms, especially small firms that form the bulk of the industry, better understand the global regulatory landscape and meet compliance standards in advanced countries.